Herbal medicines for sexually transmitted diseases and AIDS

Journal of Ethnopharmacology

Volumn 80, Issue 1, 2002, Pages 49-66

  Vermani, Kavita ^a   Garg, Sanjay ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

AIDS; Herbal medicine; Microbicides; Sexually transmitted diseases; Vagina

Indexed keywords

1 DEOXYNOJIRIMYCIN; ACICLOVIR; ANGELICA EXTRACT; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT; ANTIVIRUS AGENT; AUSTRALINE; AYURVEDIC DRUG; BERBERINE DERIVATIVE; CASTANOSPERMINE; CONCANAVALIN A; COUMARIN DERIVATIVE; CURCUMIN; ECHINACEA EXTRACT; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FAGARONINE; GINGER EXTRACT; GLYCYRRHIZA EXTRACT; GOSSYPOL; HERBACEOUS AGENT; HYPERICIN; MELISSA OFFICINALIS EXTRACT; MYRICETIN; PH 5; PHYTOESTROGEN; PLANT EXTRACT; PODOPHYLLOTOXIN; PROCYANIDIN DERIVATIVE; TEA TREE OIL; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CHLAMYDIASIS; CLINICAL FEATURE; CONDYLOMA; DRUG FORMULATION; DRUG MECHANISM; GENITAL HERPES; HERBAL MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICINAL PLANT; NONHUMAN; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; VAGINITIS; VULVOVAGINITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, MONOCLONAL; CHLAMYDIA INFECTIONS; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; PLANT EXTRACTS; PLANTS, MEDICINAL; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS VAGINITIS;

EID: 0036118546     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(02)00009-0     Document Type: Article

References (118)

1. Antiviral activity of some South American medicinal plants
2. Antiviral, hemolytic and molluscidal activities of triterpenoid saponins from Maesa lanceolata: Establishment of structure activity relationship
3. Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethopian medicinal plants
4. Alpha-(1-3) and alpha-(1-6)-D-mannose specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro
5. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat
6. Anti-HIV activity of medicinal plant extracts
7. Anti-HIV and cytotoxic alkaloids from Buchenavia capitata
8. A reinvestigation of Maprounea triterpenes
9. Tea tree oil and anaerobic (bacterial) vaginosis
10. HIV inhibitory natural products. Part 27. HIV inhibitory gallotannins from Lepidobotrys staudtii
11. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus infection in vitro
12. Plant products as topical microbicide candidates: Assessment of in vitro and in vivo activity against herpes simplex virus 2
13. Analysis of non-nucleoside drug resistant variants of human immunodeficiency virus type 1 reverse transcriptase
14. Antigonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases
15. Isolation and DNA sequence of a gene encoding alpha-trichosanthin, a type I ribosome-inactivating protein
16. Novel naphthaquinones from Conospermum incurvum
17. Structure, absolute stereochemistry and synthesis of conocurvone, a potent, novel HIV inhibitory naphthaquinone trimer from Conospermum species
18. Human immunodeficiency virus type 1 cDNA integration: New aromatic hydroxylated inhibitors and studies of the inhibition mechanism
19. Beyond latex: Will microbicides offer an alternative to condom?
20. Anti-AIDS agents, betulinic acid and platanic acid as anti-HIV principles from Syzygium claviforum, and anti-HIV activity of structurally related triterpenoids
21. Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate
22. HIV inhibitory natural products. Part 28. Diterpene carboxylic acids from fruits of Xylopia sp.
23. Praneem polyherbal cream: Phase I clinical trials in India
24. Interference with HIV induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
25. A non promoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1
26. The peltatols, novel HIV inhibitory catechol derivatives from Pothomorphe peltata
27. Circulins A and B: Novel HIV-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia
28. In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil
29. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins
30. Sexually transmitted diseases
31. Anti-human immunodeficiency virus phenolics from licorice
32. Inhibitory effects of various Ayurvedic and Panamanian medicinal plants on the infection of herpes simplex virus-1 in vitro and in vivo
33. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2
34. Antiviral activity of natural and semi-synthetic chromone alkaloids
35. Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice
36. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV)
37. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV(HTLV-III/LAV)]
38. Action of some essential oils on Trichomonas vaginalis
39. Effect of condensed tannins and related compounds on reverse transcriptase
40. A ethnobotanical study of plants used for the treatment of sexually transmitted diseases (njovhera) in Guruve District, Zimbabwe
41. Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
42. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree
43. Isolation of virus cell fusion inhibitory components from Eugenia caryophyllata
44. α-homonojirimycin (2,6-dideoxy-2,6-imino-D-glycero-L-gulo-heptitol) from Omphale diandra Linn. Isolation and glucosidase inhibition
45. Potent antiviral potamogetonyde and potamogetonol, new furanoid labdane diterpenes from Potamogeton malaianus
46. Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo
47. Purification and characterization of eugenin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum
48. Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo
49. Purification and characterization of eugenin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum
50. Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 (HIV-1) protease
51. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudehypericin
52. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon
53. MAP 30: A new inhibitor of HIV-1 infection and replication
54. A new class of anti-HIV agents: GAP31, DAPs 30 and 32
55. Anti herpes simplex virus type 1 flavonoids and a new flavonone from the root of Linonium sinense
56. Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol
57. Inhibition of HIV infection by flavonoids
58. Novel alkaloids from the tropical plant Ancistrocladus abbreviatus inhibit cell killing by HIV-1 and HIV-2
59. Effects of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the resistance of thermally injured mice infected with herpes simplex virus type 1
60. A search for antiviral properties in Panamian medicinal plants. The effect on HIV and its essential enzymes
61. HIV inhibitory natural products 26. Quinoline alkaloids from Euodia roxburghiana
62. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase
63. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aromatic polycyclic diones hypericin and pseudehypericin
64. Multicentric trial on the effect of V-gel (PDP-959 gel) in vaginitis
65. Clinical trial with Praneem polyherbal cream in patients with abnormal vaginal discharge due to microbial infections
66. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1
67. Efficacy of kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice
68. Inhibition of HIV-reverse transcriptase activity by some fluroglucinol derivatives
69. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases
70. Suppression of recurrent genital herpes simplex virus type 2 infection by Rhus javanica in guinea pigs
71. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T 22([Tyr-5,12,Lys-7] polyphemusin II): A possible inhibitor of virus-cell fusion
72. Efficacy of V-gel in vaginitis
73. Castanospermine in Alexa species
74. Anti-herpes simplex virus activity of alkaloids isolated from Stephania cepharantha
75. Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H 9 lymphocyte cells
76. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases
77. Screening of Indonesian plant extracts for anti-human immunodeficiency virus-Type1 (HIV-1) activity
78. How effective are complementary therapies for HIV and AIDS? - A systematic review
79. The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn.
80. Melaleuca alternifolia oil-its use for Trichomonal vaginalis and other vaginal infections
81. Mechanistic evaluation of new plant derived compounds that inhibit HIV-1 reverse transcriptase
82. Pentacyclic triterpenes derived from Maprounea africana are potent inhibitors of HIV-1 reverse transcriptase
83. Inactivation of human immunodeficiency virus in vitro by gossypol
84. Glycyrrhizic acid inhibits virus growth and inactivates virus particles
85. Antiviral activity of glycyrrhizic acid
86. Screening of Nepalese medicinal plants for antiviral activity
87. Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs
88. New lignans from Anogeissus acuminata with HIV-1 reverse transcriptase inhibitory activity
89. Gynecologic disorders
90. In vivo analysis of castanospermin, a candidate antiretroviral agent
91. Development of natural products
92. Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing
93. Antiviral components of Ophiorrhiza mungos. Isolation of camptothecin and 10 methoxy camptothecin
94. Praneem polyherbal cream and pessaries with dual properties of contraception and alleviation of genital infections
95. Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens
96. Plant immunomodulators for termination of unwanted pregnancy and contraception and reproductive health
97. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase
98. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase
99. Antiviral activities of medicinal plants of Southern Nepal
100. Antiviral activities of Nepalese medicinal plants
101. Antiviral activity of Viracea against acyclovir susceptible and resistant strains of herpes simplex virus
102. Effect of ribosome inactivating proteins on virus infected cells. Inhibition of virus multiplication and of protein synthesis
103. Inhibitory effects of papaverine on HIV replication in vitro
104. TXU (antiCD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus
105. Efficacy of PD-595 (V-gel) in abnormal vaginal discharge
106. Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-12-en-3 beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1
107. Can ethnopharmacology contribute to the development of antiviral drugs
108. Plant derived leading compounds for chemotherapy of human immunodeficiency virus infection
109. Solution structure of anti-HIV-1 and antitumor protein MAP 30: Structural insights into its multiple functions
110. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases
111. Prevention of binding of gp 120 by anti-HIV tannins
112. Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent
113. Local therapies of herpes simplex with dried extract from Melissa officinalis
114. Natural products based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program
115. Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases